★ INSERT COIN◆NOW PLAYING: VENTURES◆HIGH SCORE: $100M ARR◆★ NEW STAGE UNLOCKED: ABOUT ME◆PRESS START◆★ DEMO DAY 04:00:00◆
★ INSERT COIN◆NOW PLAYING: VENTURES◆HIGH SCORE: $100M ARR◆★ NEW STAGE UNLOCKED: ABOUT ME◆PRESS START◆★ DEMO DAY 04:00:00◆
◀ BACK TO FEED
NEWS★ HEALTHTECHNOV 13, 2026

Bracco introduces UPTUNITY aneurysm AI after FDA clearance

Bracco and Avicenna.AI introduce aneurysm detection and assessment software within a new clinical AI portfolio.

Bracco introduces UPTUNITY aneurysm AI after FDA clearance

Bracco is building a clinical AI portfolio around radiology workflows.

What happened

Bracco and Avicenna.AI announced UPTUNITY | Aneurysm on 13 November. The software supports brain-aneurysm detection and assessment on CT angiography and introduces Bracco's UPTUNITY clinical-decision-support portfolio. The announcement follows an October FDA clearance decision for the underlying CINA-Aneurysm+ component.

Why it matters

The partnership connects a specialist imaging-AI developer with an established radiology supplier. That creates a route for decision-support software to reach the clinicians and institutions already using imaging products.

The bigger picture

Medical AI adoption involves distribution, integration and clinical reading processes. A portfolio approach gives a supplier a way to bring specialised tools into those existing relationships.

#BRACCO#AVICENNA.AI#MEDICAL IMAGING#ANEURYSM